Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?
Received date: 19 Sep 2022
Accepted date: 06 Oct 2022
Published date: 15 Dec 2022
Copyright
David Carling . Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?[J]. Life Metabolism, 2022 , 1(3) : 209 -210 . DOI: 10.1093/lifemeta/loac027
| 1 |
Steinberg GR , Carling D . Nat Rev Drug Discov 2019; 18: 527- 51.
|
| 2 |
Zhang CS , Li M , Wang Y et al. Nat Metab 2022; 4: 1369- 401.
|
| 3 |
Zhang CS , Hawley SA , Zong Y et al. Nature 2017; 548: 112- 6.
|
| 4 |
Zhang YL , Guo H , Zhang CS et al. Cell Metab 2013; 18: 546- 55.
|
| 5 |
Li M , Zhang CS , Feng JW et al. Cell Metab 2019; 30: 508- 24.
|
| 6 |
Zong Y , Zhang CS , Li M et al. Cell Res 2019; 29: 460- 73.
|
| 7 |
Gluais-Dagorn P , Foretz M , Steinberg GR et al. Hepatol Commun 2022; 6: 101- 19.
|
| 8 |
Myers RW , Guan HP , Ehrhart J et al. Science 2017; 357: 507- 11.
|
| 9 |
Pollard AE , Martins L , Muckett PJ et al. Nat Metab 2019; 1: 340- 9.
|
| 10 |
Apfeld J , O’Connor G , McDonagh T et al. Genes Dev 2004; 18: 3004- 9.
|
/
| 〈 |
|
〉 |